David Bauché

2PUBLICATIONS
5CO-AUTHORS
Molecular targetsImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Oct 31, 2020
Antitumor efficacy of combined CTLA4/PD-1 blockade without intestinal inflammation is achieved by elimination of FcγR interactions.

David Bauché, Smita Mauze, Christina Kochel

|Apr 26, 2020
IL-23 and IL-2 activation of STAT5 is required for optimal IL-22 production in ILC3s during colitis.

David Bauché, Barbara Joyce-Shaikh, Julie Fong

Pageof 1